Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriers.

Source:http://linkedlifedata.com/resource/pubmed/id/3438668

Download in:

View as

General Info

PMID
3438668